Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2014 1
2015 1
2016 1
2018 1
2019 1
2020 1
2021 1
2022 2
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
EFFICACY OF INTRACAMERAL MOXIFLOXACIN VERSUS TOPICAL MOXIFLOXACIN IN PREVENTING ACUTE ENDOPHTHALMITIS AFTER CATARACT SURGERY BY PHACOEMULSIFICATION.
Anwar F, Qamar N, Bashir A, Ghaffar MT, Bokhari MH. Anwar F, et al. J Ayub Med Coll Abbottabad. 2024 Apr-Jun;36(2):256-259. doi: 10.55519/JAMC-02-12663. J Ayub Med Coll Abbottabad. 2024. PMID: 39609960 Free article. Clinical Trial.
Most common route of infection is exogenous either after the surgery or traumatic perforation Objectives were of evaluate the efficacy of intracameral moxifloxacin versus topical moxifloxacin in preventing postoperative acute endophthalmitis after cataract su …
Most common route of infection is exogenous either after the surgery or traumatic perforation Objectives were of evaluate the efficacy of …
Macular and choroidal thickness after intracameral moxifloxacin for prevention of postcataract endophthalmitis.
Ferreira BG, Cardoso da Silva I, Mélega MV, Nascimento MA, Cavalcanti Lira RP, Leite Arieta CE, Alves M. Ferreira BG, et al. J Cataract Refract Surg. 2021 Jan 1;47(1):40-45. doi: 10.1097/j.jcrs.0000000000000365. J Cataract Refract Surg. 2021. PMID: 32818353 Clinical Trial.
PURPOSE: To determine any changes in macular or choroidal thickness associated with the use of intracameral moxifloxacin as postcataract endophthalmitis prophylaxis. SETTING: University of Campinas, Campinas, Sao Paulo, Brazil. ...METHODS: Phacoemulsification surger …
PURPOSE: To determine any changes in macular or choroidal thickness associated with the use of intracameral moxifloxacin as po …
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial.
Melega MV, Alves M, Cavalcanti Lira RP, Cardoso da Silva I, Ferreira BG, Assis Filho HL, Pedreira Chaves FR, Martini AAF, Dias Freire LM, Reis RD, Leite Arieta CE. Melega MV, et al. J Cataract Refract Surg. 2019 Mar;45(3):343-350. doi: 10.1016/j.jcrs.2018.10.044. Epub 2019 Jan 25. J Cataract Refract Surg. 2019. PMID: 30691922 Clinical Trial.
PURPOSE: To evaluate the safety and efficacy of intracameral (IC) 0.5% moxifloxacin in the prevention of post-cataract endophthalmitis. SETTING: University of Campinas, Sao Paulo, Brazil. ...METHODS: Patients who had phacoemulsification were randomized into two grou …
PURPOSE: To evaluate the safety and efficacy of intracameral (IC) 0.5% moxifloxacin in the prevention of post-cataract endopht …
Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis.
Bowen RC, Zhou AX, Bondalapati S, Lawyer TW, Snow KB, Evans PR, Bardsley T, McFarland M, Kliethermes M, Shi D, Mamalis CA, Greene T, Rudnisky CJ, Ambati BK. Bowen RC, et al. Br J Ophthalmol. 2018 Sep;102(9):1268-1276. doi: 10.1136/bjophthalmol-2017-311051. Epub 2018 Jan 11. Br J Ophthalmol. 2018. PMID: 29326317 Free PMC article.
The average weighted postoperative endophthalmitis incidence rates with intracameral cefuroxime, moxifloxacin and vancomycin were 0.0332%, 0.0153% and 0.0106%, respectively. ...CONCLUSION: Intracameral cefuroxime and moxifloxacin reduced endophthalmiti …
The average weighted postoperative endophthalmitis incidence rates with intracameral cefuroxime, moxifloxacin and vancomycin w …
Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification.
Chang DF, Prajna NV, Szczotka-Flynn LB, Benetz BA, Lass JH, OʼBrien RC, Menegay HJ, Gardner S, Shekar M, Rajendrababu S, Rhee DJ. Chang DF, et al. J Cataract Refract Surg. 2020 Mar;46(3):355-359. doi: 10.1097/j.jcrs.0000000000000064. J Cataract Refract Surg. 2020. PMID: 32050222 Clinical Trial.
PURPOSE: To determine whether intracameral moxifloxacin 500 mug is noninferior to 250 mug for central endothelial cell loss (ECL) after phacoemulsification. ...Intraoperatively, the first eye was randomized to receive either a 500 or 250 mug dose of moxifloxacin …
PURPOSE: To determine whether intracameral moxifloxacin 500 mug is noninferior to 250 mug for central endothelial cell loss (E …
Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.
Lane SS, Osher RH, Masket S, Belani S. Lane SS, et al. J Cataract Refract Surg. 2008 Sep;34(9):1451-9. doi: 10.1016/j.jcrs.2008.05.034. J Cataract Refract Surg. 2008. PMID: 18721703 Clinical Trial.
PURPOSE: To evaluate posterior and anterior segment safety of an intracameral injection of moxifloxacin 0.5% ophthalmic solution as prophylaxis for endophthalmitis in patients having cataract surgery. ...CONCLUSION: There was no increased safety risk associated with …
PURPOSE: To evaluate posterior and anterior segment safety of an intracameral injection of moxifloxacin 0.5% ophthalmic soluti …
Intracameral dexamethasone 9% vs prednisolone acetate 1% in controlling postoperative pain and inflammation in patients undergoing cataract surgery.
Hovanesian JA, Donnenfeld ED. Hovanesian JA, et al. J Cataract Refract Surg. 2022 Aug 1;48(8):906-911. doi: 10.1097/j.jcrs.0000000000000887. Epub 2022 Jan 18. J Cataract Refract Surg. 2022. PMID: 35067660 Clinical Trial.
In this contralateral eye study, 1 eye of each patient was randomized to the 1-drop regimen of intracameral delivery of moxifloxacin and dexamethasone suspension and topical bromfenac for 30 days. ...Macular thickness and mean IOP were similar between groups. CONCLU …
In this contralateral eye study, 1 eye of each patient was randomized to the 1-drop regimen of intracameral delivery of moxifloxac …
Antibiotic prevention of postcataract endophthalmitis: a systematic review and meta-analysis.
Kessel L, Flesner P, Andresen J, Erngaard D, Tendal B, Hjortdal J. Kessel L, et al. Acta Ophthalmol. 2015 Jun;93(4):303-17. doi: 10.1111/aos.12684. Epub 2015 Mar 16. Acta Ophthalmol. 2015. PMID: 25779209 Free PMC article. Review.
We found high-to-moderate quality evidence for a marked reduction in the risk of endophthalmitis with the use of intracameral antibiotic administration of cefazolin, cefuroxime and moxifloxacin, whereas no effect was found with the use of topical antibiotics or i …
We found high-to-moderate quality evidence for a marked reduction in the risk of endophthalmitis with the use of intracameral antibio …
Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes.
Kato A, Horita N, Namkoong H, Nomura E, Masuhara N, Kaneko T, Mizuki N, Takeuchi M. Kato A, et al. Sci Rep. 2022 Oct 18;12(1):17416. doi: 10.1038/s41598-022-21423-w. Sci Rep. 2022. PMID: 36258003 Free PMC article.
While one randomized controlled trial supported each of intracameral cefuroxime and moxifloxacin, no randomized controlled trial evaluated vancomycin and cefazoline. ...In conclusion, intracameral injection of either vancomycin, cefazoline, cefuroxime, or …
While one randomized controlled trial supported each of intracameral cefuroxime and moxifloxacin, no randomized controlled tri …
Comparison of intracameral dexamethasone and intracameral triamcinolone acetonide injection at the end of phacoemulsification surgery.
Gungor SG, Bulam B, Akman A, Colak M. Gungor SG, et al. Indian J Ophthalmol. 2014 Aug;62(8):861-4. doi: 10.4103/0301-4738.141045. Indian J Ophthalmol. 2014. PMID: 25230962 Free PMC article. Clinical Trial.
PURPOSE: To compare the results of intracameral dexamethasone and intracameral triamcinolone acetonide injection in patients that underwent cataract surgery with phacoemulsification. ...The mean intraocular pressures on days 7 and 30 after surgery were not statistic …
PURPOSE: To compare the results of intracameral dexamethasone and intracameral triamcinolone acetonide injection in patients t …
11 results

Searches related to "intracameral moxifloxacin"